RANDOMIZED, DOUBLE-BLIND PHASE III STUDY OF PAZOPANIB IN PATIENTS WITH ADVANCED/METASTATIC RENAL CELL CARCINOMA (MRCC): FINAL OVERALL SURVIVAL (OS) RESULTS
ANNALS OF ONCOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2010)